Liver transplantation for sinusoidal obstructive syndrome (veno‐occlusive disease): case report with review of the literature and the UNOS database
- 18 July 2008
- journal article
- case report
- Published by Wiley in Clinical Transplantation
- Vol. 22 (4), 397-404
- https://doi.org/10.1111/j.1399-0012.2008.00814.x
Abstract
Severe sinusoidal obstructive syndrome (SOS) is a life-threatening complication of stem cell transplantation. We report the case of a young man transplanted for SOS. A single chart review with query of the United Network of Organ Sharing database and review of the medical literature. A 23-yr-old male diagnosed with chronic myeloid leukemia underwent a matched unrelated stem cell transplant. The conditioning regimen included high-dose cyclophosphamide and busulfan. Within one month, he developed painful hepatomegaly, jaundice, ascites, and weight gain, and was diagnosed with biopsy-proven SOS. Despite therapy with defibrotide, he continued to deteriorate with the development of progressive renal failure and encephalopathy. The patient underwent orthotopic liver transplantation. After surgery, he developed cytomegalovirus infection and six wk later presented with a bile leak, hepatic artery thrombosis, and a liver abscess. A repeat bone marrow biopsy showed no evidence of recurrent disease. Although the patient was listed for re-transplantation, he succumbed prior to an organ becoming available. Severe SOS in the setting of bone marrow transplantation portends a poor prognosis. Careful patient selection, timing, and perhaps less immunosuppression should be considered when performing a liver transplantation in the setting of severe SOS.Keywords
This publication has 36 references indexed in Scilit:
- TIPS for veno-occlusive disease: Is the contraindication real?Hepatology, 2005
- A Successful Liver Transplantation for Refractory Hepatic Veno‐Occlusive Disease Originating from Cord Blood TransplantationAmerican Journal of Transplantation, 2002
- Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)Seminars in Liver Disease, 2002
- N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantationBone Marrow Transplantation, 2000
- Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?Bone Marrow Transplantation, 2000
- Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantationBone Marrow Transplantation, 1997
- TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE PLAMINOGEN ACTIVATOR OR ORTHOTOPIC LIVER TRANSPLANTATION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION1Transplantation, 1996
- Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liverLiver Transplantation and Surgery, 1996
- Prophylactic heparin does not prevent liver veno‐occlusive disease following autologous bone marrow transplantationEuropean Journal of Haematology, 1991
- Use of prostaglandin E1 for prevention of liver veno‐occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantationBritish Journal of Haematology, 1990